Citius Oncology (CTOR) vs Rallybio (RLYB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rallybio (RLYB) has outperformed Citius Oncology (CTOR) over the past year, gaining 277.9% versus a loss of 54.7%. Citius Oncology is the larger company by market cap ($90.0 million vs $89.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | RLYB |
|---|---|---|
| Share price | $0.851 | $16.93 |
| Market cap | $90.00M | $89.94M |
| 1-day change | +0.12% | -0.88% |
| YTD return | -14.90% | +208.49% |
| 1-year return | -54.73% | +277.90% |
| 5-year return | — | -86.36% |
| P/E ratio (TTM) | — | 2.11 |
| EPS (TTM) | $-0.48 | $8.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $17.57 |
| 52-week low | $0.491 | $3.67 |
| Distance from 52-week high | -62.18% | -3.66% |
| Average volume | 99.72K | 22.16K |
| Shares outstanding | 105.76M | 5.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RLYB has outperformed CTOR by 332.6 percentage points over the past year.
CTOR vs RLYB FAQ
Which is bigger, Citius Oncology or Rallybio?
Citius Oncology (CTOR) is larger, with a market capitalization of $90.00M compared with $89.94M for Rallybio (RLYB).
Which stock has performed better over the past year, CTOR or RLYB?
RLYB returned +277.90% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Rallybio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.